Genocea BiosciencesGNCAQ

13F holders, Q1 2024 (March 31)
1holders
$0.00avg. 13F price*

At the end of Q1 2024, 1 institutions reported holding Genocea Biosciences Inc. (GNCAQ) in their 13F filings. The largest holder was Madison Park Capital Advisors, LLC ($0).

Company
Genocea Biosciences Inc.
CUSIP
372427401
Latest filing quarter
Q1 2026

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026

Total Exit/New Position Q1 2024

No earlier quarter to compare with.

Ownership 1 holders

Madison Park Capital Advisors, LLC 0.00% No change 10,000 $0

"% of holder's portfolio" is GNCAQ's weight in each manager's 13F, not the share of Genocea Biosciences Inc. the manager owns.